What is Trayt?
Trayt operates as a patient-centric data analytics platform dedicated to transforming the diagnostic and treatment landscape for individuals with autism, ADHD, and various brain disorders. By developing sophisticated tools that measure the efficacy of therapeutic interventions, the company enables a more precise approach to personalized medicine. Its platform facilitates seamless collaboration across the entire care ecosystem, allowing providers, families, and researchers to track, measure, and share critical behavioral and medical outcomes in real-time. This data-driven methodology is essential for improving the quality of life for patients while providing clinicians with actionable insights to optimize treatment protocols.
How much funding has Trayt raised?
Trayt has raised a total of $7.2M across 1 funding round:
Stock/Share Issuance
$7.2M
Stock/Share Issuance (2026): $7.2M, investors not publicly disclosed
Key Investors in Trayt
Trayt
Undisclosed investor participating in the funding round.
What's next for Trayt?
With this major enterprise-level funding, Trayt is poised to scale its operations and enhance its proprietary analytics engine. The strategic roadmap likely involves deepening its integration with existing electronic health record systems and expanding its reach into broader clinical networks. By leveraging this capital, the company aims to standardize outcome measurement in behavioral health, a move that could fundamentally shift how payers and providers evaluate the success of neurodevelopmental treatments. As the firm enters this next phase of growth, the focus will remain on scaling its infrastructure to support larger institutional partnerships and driving long-term value through improved patient-centric care models.
See full Trayt company page
